Prostate Specific Antigen, Complexed
2002930
 
Ordering Recommendation
Mnemonic
PSA COMP
Methodology
Chemiluminescent Immunoassay
Performed
Sun
Reported
1-8 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Plain red or serum separator tube.  
Specimen Preparation
Transfer 1.0 mL serum to an ARUP standard transport tube. (Min: 0.5 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Hemolyzed specimens. Any specimens other than serum.  
Remarks
 
Stability
Ambient: 8 hours; Refrigerated: 1 week; Frozen: 1 month  
Reference Interval
0 - 3.6 ng/mL
Interpretive Data
This test uses the Siemens' ADVIA Centaur cPSA methodology, which is FDA approved for use as an aid in the detection of prostate cancer in men age 50 and older when used in conjunction with a digital rectal exam. This methodology is also approved as an aid in the management/monitoring of prostate cancer patients. Results obtained with different assay methods or kits cannot be used interchangeably. Prostatic biopsy is required for the diagnosis of cancer. cPSA is generally not elevated in healthy men or with non-prostatic carcinoma. cPSA concentrations may be elevated in benign prostatic hyperplasia or inflammatory conditions of the prostate. Prostate cancer patients under treatment with antiandrogens and LHRH agonists and antagonists may exhibit markedly reduced levels of cPSA. Care should be taken when interpreting values from these individuals.
Note
CPT Code(s)
84152
Components
Component Test Code*Component Chart Name
2002931PSA Complexed
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • Complexed PSA
  • cPSA